Table 4 Comparison of clinical outcome: numbers, percentages, crude and adjusted outcome measurements for the two patient groups
Outcome | Group 1 2019 (137 Pts) n (%) | Group 2 2020 (109 Pts) n (%) | Crude OR (95% CI), p-value | Adjusted OR* (95% CI), p-value |
|---|---|---|---|---|
ICU admissions, n (%) | 9 (6.9) | 3 (3.1) | N/A, p = 0.24 | |
Intra-operative complications, n (%) | 0 (0) | 1 (1) | N/A, p = 0.43 | |
Post-operative LOS, median (q1–q3) | 3 (1-8) | 4 (2-9) | N/A, p = 0.13 | |
Morbidity | 15 (11.5) | 22 (22.4) | OR = 2.22 (1.08–4.55), p = 0.03 | aOR = 2.28 (1.04–5.03), p = 0.04 |
Dindo-Clavien 0–2 | 121 (93.1) | 87 (88.8) | ||
Dindo-Clavien 3–4 | 8 (6.1) | 9 (9.2) | ||
Dindo-Clavien 5 | 1 (0.8) | 2 (2.0) | ||
Blood transfusion | 17 (13.1) | 8 (8.2) | OR = 0.59 (0.24–1.43), p = 0.24 | aOR = 0.52 (0.19–1.40), p = 0.20 |
Death/in-hospital mortality | 1 (0.7) | 2 (1.8) | OR = 2.52 (0.23–28.20), p = 0.45 | aOR = 4.38 (0.19–99.78), p = 0.35 |
30-day mortality | 4 (3.1) | 4 (4.1) | OR = 1.34 (0.33–5.50), p = 0.68 | aOR = 1.65 (0.33–8.29), p = 0.54 |